| Patient and public involvement in covid-19 policy making T Richards, H Scowcroft bmj 370, 2020 | 98 | 2020 |
| Caeruloplasmin isoforms in Wilson's disease in neonates G Chowrimootoo, H Scowcroft, C Seymour Archives of disease in childhood. Fetal and neonatal edition 79 (3), F198, 1998 | 20 | 1998 |
| Healthcare decision making should be democratised T Richards, H Scowcroft, E Doble, A Price, K Abbasi bmj 373, 2021 | 13 | 2021 |
| Communication of anticancer drug benefits and related uncertainties to patients and clinicians: document analysis of regulated information on prescription drugs in Europe C Davis, AK Wagner, M Salcher-Konrad, H Scowcroft, B Mintzes, ... bmj 380, 2023 | 11 | 2023 |
| Mortality benefits and overdiagnosis estimates for women attending breast screening N Ormiston-Smith, H Scowcroft, CS Thomson British journal of cancer 108 (11), 2413-2414, 2013 | 5 | 2013 |
| Protecting “covid protected” cancer hubs C Swanton, H Scowcroft BMJ 369, 2020 | 4 | 2020 |
| Access to personal health records—why is progress so slow? E Doble, H Scowcroft bmj 375, 2021 | 1 | 2021 |
| Patient partnership: a roundup from the BMJ patient advisory panel E Doble, H Scowcroft bmj 374, 2021 | 1 | 2021 |
| Why are breast cancer rates increasing? H Scowcroft https://scienceblog.cancerresearchuk.org/2011/02/04/why-are-breast-cancer …, 2011 | 1 | 2011 |
